Cas:145934-59-4 3-methoxy-2-methyl-1H-pyrrolo[2,3-b]pyridine manufacturer & supplier

Chemical Name:3-methoxy-2-methyl-1H-pyrrolo[2,3-b]pyridine

CAS.NO:145934-59-4

Synonyms:1H-Pyrrolo[2,3-b]pyridine,3-methoxy-2-methyl;3-Methoxy-2-methylpyrrolo[2,3-b]pyridine

Molecular Formula:C₉H₁₀N₂O

Molecular Weight:162.18800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:316.2ºC at 760 mmHg

Density:1.198g/cm3

Index of Refraction:1.629

PSA:37.91000

Exact Mass:162.07900

LogP:1.87990

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrrolo[2,3-b]pyridine,3-methoxy-2-methyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Methoxy-2-methylpyrrolo[2,3-b]pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methoxy-2-methylpyrrolo[2,3-b]pyridine Use and application,3-Methoxy-2-methylpyrrolo[2,3-b]pyridine technical grade,usp/ep/jp grade.

Related News: In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 3-methoxy-2-methyl-1H-pyrrolo[2,3-b]pyridine manufacturer Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 3-methoxy-2-methyl-1H-pyrrolo[2,3-b]pyridine supplier In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 3-methoxy-2-methyl-1H-pyrrolo[2,3-b]pyridine vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 3-methoxy-2-methyl-1H-pyrrolo[2,3-b]pyridine factory The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.